title: Platelet Function Tests in Bleeding Disorders.
abstract: Functional disorders of platelets can involve any aspect of platelet physiology, with many different effects or outcomes. These include platelet numbers (thrombocytosis or thrombocytopenia); changes in platelet production or destruction, or capture to the liver (Ashwell receptor); altered adhesion to vascular injury sites and/or influence on hemostasis and wound healing; and altered activation or receptor functions, shape change, spreading and release reactions, procoagulant and antifibrinolytic activity. Procoagulant membrane alterations, and generation of thrombin and fibrin, also affect platelet aggregation. The above parameters can all be studied, but standardization and quality control of assay methods have been limited despite several efforts. Only after a comprehensive clinical bleeding assessment, including family history, information on drug use affecting platelets, and exclusion of coagulation factor, and tissue deficits, should platelet function testing be undertaken to confirm an abnormality. Current diagnostic tools include blood cell counts, platelet characteristics according to the cell counter parameters, peripheral blood smear, exclusion of pseudothrombocytopenia, whole blood aggregometry (WBA) or light transmission aggregometry (LTA) in platelet-rich plasma, luminescence, platelet function analysis (PFA-100) for platelet adhesion and deposition to collagen cartridges under blood flow, and finally transmission electron microscopy to exclude rare structural defects leading to functional deficits. The most validated test panels are included in WBA, LTA, and PFA. Because platelets are isolated from their natural environment, many simplifications occur, as circulating blood and interaction with vascular wall are omitted in these assays. The target to reach a highly specific platelet disorder diagnosis in routine clinical management can be exhaustive, unless needed for genetic counseling. The elective overall assessment of platelet function disorder primarily aims at better management of hemostasis in case of emergency surgery or other interventions and acute bleeding events.
authors.affiliation: Coagulation Disorders, Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
authors.forename: Riitta
authors.initials: R
authors.lastname: Lassila
mesh_terms: D001791:Blood Platelet Disorders / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology; D001792:Blood Platelets / Q000378:metabolism / Q000502:physiology*; D006474:Hemorrhagic Disorders / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology*; D006801:Humans; D008954:Models, Biological; D010973:Platelet Adhesiveness / Q000502:physiology*; D010974:Platelet Aggregation / Q000502:physiology*; D010976:Platelet Count; D010979:Platelet Function Tests / Q000379:methods*; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism
chemical_list: D010980:Platelet Membrane Glycoproteins